Open | $4.510 |
Close | $4.470 |
Volume / Avg. | 59.357K / 151.071K |
Day Range | 4.400 - 4.770 |
52 Wk Range | 2.730 - 48.790 |
Market Cap | $6.047M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | % |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vivos Therapeutics (NASDAQ: VVOS) through any online brokerage.
Other companies in Vivos Therapeutics’s space includes: Aesthetic Medical Intl (NASDAQ:AIH), ATI Physical Therapy (NYSE:ATIP), Precipio (NASDAQ:PRPO), Psychemedics (NASDAQ:PMD) and Star Equity Hldgs (NASDAQ:STRR).
The latest price target for Vivos Therapeutics (NASDAQ: VVOS) was reported by Ascendiant Capital on Tuesday, January 17, 2023. The analyst firm set a price target for 2.50 expecting VVOS to fall to within 12 months (a possible -44.93% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Vivos Therapeutics (NASDAQ: VVOS) is $4.54 last updated March 18, 2024 at 6:09 PM EDT.
There are no upcoming dividends for Vivos Therapeutics.
Vivos Therapeutics’s Q1 earnings are confirmed for Thursday, June 6, 2024.
There is no upcoming split for Vivos Therapeutics.
Vivos Therapeutics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.